0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > TDO2

TDO2

Brief Information

Name:Tryptophan 2,3-dioxygenase
Target Synonym:TDO,EC 1.13.11.11,HYPTRP,TPH2,Tryptophan Oxygenase,TDO2,TO,Tryptophan pyrrolase,Tryptophan 2,3-Dioxygenase,Tryptamin 2,3-Dioxygenase,Tryptophanase,TRPO,EC:1.13.11.11
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
TD2-H5143 Human Human TDO2 Protein, His Tag
TD2-H5143-structure
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
LPM-3480226 LY-01013; LPM-3480226 Phase 1 Clinical Luye Pharma Group Ltd Solid tumours Details
SHR-9146 HTI-1090; SHR-9146 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Solid tumours; Neoplasms Details
DN-1406131 DN-131; DN-1406131 Phase 1 Clinical Jiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co Ltd Solid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken